Sysmex's haematology analyser:
This article was originally published in Clinica
The XE-5000 automated haematology analyser developed by Sysmex America has been granted 510(k) approval by the US FDA. It uses Sysmex's fluorescent flow cytometry technology to provide both routine haematology testing and abnormal cell flagging within a single sample run. The XE-5000 can be remotely monitored by Sysmex technicians, who can help correct any issues prior to system or part failures. The device will be on sale in the US, Latin America and in Canada within the month and is aimed at hospital or university laboratories and clinics with renal, oncology and acute care patient populations. Sysmex America, of Mundelein, Illinois, is the US headquarters of Kobe, Japan-based Sysmex.
You may also be interested in...
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.
Which drug candidates represent hope, and which hype? The Scrip team examine the COVID-19 pipeline, lessons from China, and some long term impacts on the sector.
China insists there is no double standard and won’t tolerate any quality issues in its centralized procurement process.